User profiles for DANIEL ALETAHA
Daniel AletahaProfessor of Rheumatology, Medical University Vienna Verified email at meduniwien.ac.at Cited by 68456 |
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
…, M Voshaar, R Van Vollenhoven, D Aletaha… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …
Against Rheumatism (EULAR) RA management recommendations. A large international Task …
Treating rheumatoid arthritis to target: recommendations of an international task force
JS Smolen, D Aletaha, JWJ Bijlsma… - Annals of the …, 2010 - ard.bmj.com
Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
…, LHD Van Tuyl, J Funovits, D Aletaha… - Arthritis & …, 2011 - Wiley Online Library
Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …
is no widely used definition of remission that is stringent but achievable and could be …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
…, RF Van Vollenhoven, M De Wit, D Aletaha… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …
and consensual international recommendations on RA treatment are not available. In this …
Diagnosis and management of rheumatoid arthritis: a review
D Aletaha, JS Smolen - Jama, 2018 - jamanetwork.com
Importance Rheumatoid arthritis (RA) occurs in about 5 per 1000 people and can lead to
severe joint damage and disability. Significant progress has been made over the past 2 …
severe joint damage and disability. Significant progress has been made over the past 2 …
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …
New therapies for treatment of rheumatoid arthritis
JS Smolen, D Aletaha, M Koeller, MH Weisman… - The lancet, 2007 - thelancet.com
Rheumatoid arthritis is characterised by pain, swelling, and destruction of joints, with
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease …
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease …
Related searches
- daniel aletaha rheumatoid arthritis josef
- daniel aletaha rheumatology
- daniel aletaha abbvie
- daniel aletaha speakers bureau
- daniel aletaha md
- daniel aletaha grant
- daniel aletaha amgen
- daniel aletaha bristol-myers squibb
- daniel aletaha lilly
- daniel aletaha roche
- daniel aletaha novartis
- daniel aletaha pfizer
- daniel aletaha ucb
- daniel aletaha none declared
- daniel aletaha sanofi
- daniel aletaha janssen